Rozetta Exhibits Rakuyaku AI, an AI Solution for the Pharmaceutical Industry, at Interphex Week Tokyo / Pharma DX EXPO Tokyo
NQ Score
78/100
Key facts
- Rozetta Exhibits Rakuyaku AI, an AI Solution for the Pharmaceutical Industry, at Interphex Week Tokyo / Pharma DX EXPO Tokyo
- Rozetta Corp., a subsidiary of Metareal Corp., will exhibit at 'Pharma DX EXPO Tokyo' held at Makuhari Messe from May 20-22, 2026. The company will showcase 'Rakuyaku AI,' a specialized generative AI solution for pharmaceutical document creation, alongside new products like 'Rakuyaku SOP Editor,' 'Rakuyaku Q&A Assist,' and 'Rakuyaku MW Editor.' These tools aim to eliminate inefficiencies in the pharmaceutical industry and accelerate time-to-market for drugs. An exhibitor seminar on the Rakuyaku
- Source: PR TIMES
- Date: Sat May 16 2026 00:30:02 GMT+0900 (Japan Standard Time)
Direct answer
Rozetta Corp., a subsidiary of Metareal Corp., will exhibit at 'Pharma DX EXPO Tokyo' held at Makuhari Messe from May 20-22, 2026. The company will showcase 'Rakuyaku AI,' a specialized generative AI solution for pharmaceutical document creation, alongside new products like 'Rakuyaku SOP Editor,' 'Rakuyaku Q&A Assist,' and 'Rakuyaku MW Editor.' These tools aim to eliminate inefficiencies in the pharmaceutical industry and accelerate time-to-market for drugs. An exhibitor seminar on the Rakuyaku
- Citation
- Rozetta Exhibits Rakuyaku AI, an AI Solution for the Pharmaceutical Industry, at Interphex Week Tokyo / Pharma DX EXPO Tokyo (Sat May 16 2026 00:30:02 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Sat May 16 2026 00:30:02 GMT+0900 (Japan Standard Time)
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What are the key facts in this article?
- A: Rozetta Corp., a subsidiary of Metareal Corp., will exhibit at 'Pharma DX EXPO Tokyo' held at Makuhari Messe from May 20-22, 2026. The company will showcase 'Rakuyaku AI,' a specialized generative AI solution for pharmaceutical document creation, alongside new products like 'Rakuyaku SOP Editor,' 'Rakuyaku Q&A Assist,' and 'Rakuyaku MW Editor.' These tools aim to eliminate inefficiencies in the pharmaceutical industry and accelerate time-to-market for drugs. An exhibitor seminar on the Rakuyaku
- Q: What is the direct answer?
- A: Rozetta Corp., a subsidiary of Metareal Corp., will exhibit at 'Pharma DX EXPO Tokyo' held at Makuhari Messe from May 20-22, 2026. The company will showcase 'Rakuyaku AI,' a specialized generative AI solution for pharmaceutical document creation, alongside new products like 'Rakuyaku SOP Editor,' 'Rakuyaku Q&A Assist,' and 'Rakuyaku MW Editor.' These tools aim to eliminate inefficiencies in the pharmaceutical industry and accelerate time-to-market for drugs. An exhibitor seminar on the Rakuyaku
- Q: What is the source and date?
- A: Source: https://prtimes.jp/main/html/rd/p/000000813.000006279.html | Date: Sat May 16 2026 00:30:02 GMT+0900 (Japan Standard Time)